> ## Content Index
> Fetch the complete content index at: https://med-techinsights.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Afon to sign agreement with Sony UK TEC for wearable blood glucose indicator
- URL: https://med-techinsights.com/afon-to-sign-manufacturing-deal-for-diabetes-management-wearable/
- Published: 2025-10-29T09:40:52.000Z
- Updated: 2026-10-22T07:49:29.000Z
- Description: Afon Technology Ltd, a company based in Monmouthshire, Wales, is finalising a manufacturing agreement with Sony UK Technology Centre (TEC) Limited to produce its Glucowear device. According to Afon, Glucowear is the world’s first non-invasive, real-time wearable blood glucose indicator and is design
- Author: Oliver Johnson
- Tags: Medical Device Manufacturing, News

[**Afon Technology Ltd,**](https://afontechnology.com/?ref=med-techinsights.com) a company based in Monmouthshire, Wales, is finalising a manufacturing agreement with [**Sony UK Technology Centre**](https://www.sonypencoed.co.uk/?ref=med-techinsights.com) (TEC) Limited to produce its Glucowear device.

According to Afon, Glucowear is the world’s first non-invasive, real-time wearable blood glucose indicator and is designed to improve the lives of people with diabetes. 

The device is worn on the underside of the wrist and uses Bluetooth technology to transmit real-time glucose data to a companion app. The app displays personalised glucose trends and alerts users to high or low glucose levels, and is compatible with smartphones, smartwatches and tablets.

Sabih Chaudhry, CEO of Afon Technology Limited said: “The current trial agreement we have with Sony UK TEC marks a pivotal moment in our journey to transform diabetes management. 

“Partnering with such a globally respected manufacturer will give us the capability and confidence to bring Glucowear to market at scale, ensuring the highest standards of regulatory compliance, product quality, and technical innovation.”

He added: “We would like to thank Sony UK TEC in its recognition of our innovation, in conjunction with the credibility this brings from the manufacturing expertise of Sony. We are one step closer to delivering a truly life-changing solution to millions of people living with diabetes worldwide.” 

Ian Worgan, General Manager for Supply Chain and Business Development at Sony UK TEC said: “As a Wales-based manufacturer, we’re excited to work with an innovative Welsh company which is bringing emerging technologies to market. 

“With our expert contract manufacturing solutions, we’re always looking for our next opportunity to add value, collaborate and help our customers succeed.”

Welsh Government Cabinet Secretary for Economy, Energy and Planning, Rebecca Evans said: “We are fostering a vibrant innovation culture here in Wales, which is pushing the boundaries of science and tackling critical challenges in areas such as climate change, industrial competitiveness, and medical treatment.

“Afon Technology’s pioneering work benefitted from the EU’s flagship research and innovation programme, Horizon Europe, after Welsh Government lobbied continued involvement post Brexit, and this agreement with technology powerhouse Sony is a strong endorsement of its potential to change the lives of those living with diabetes.”